Come stanno i Milanesi - ASL Milano

Elenco delle sezioni principali del sito:

You are: Cancer » Ovary » Ladies

Ovary - Ladies

Rates per 100,000 inhabitants

Table 1: Incidence: frequencies, crude and standardized rates per year

Incidence		1999	2000	2001	2002	2003	2004	2005	2006	1999‑2006
Count		146	167	155	147	137	144	129	131	1156
Crude rate		21.5	24.7	23.0	22.0	20.6	21.3	18.8	19.0	21.4 (20.1‑22.6)
Standardized rate	Italy 2001	17.4	19.5	18.6	17.2	15.9	16.7	14.7	15.6	16.9 (16.0‑18.0)
Standardized rate	Europe	13.2	14.8	14.9	13.3	12.1	12.9	11.0	12.4	13.1 (12.3‑13.9)
Standardized rate	World	9.6	10.5	10.7	9.3	8.6	9.2	7.9	9.2	9.4 (8.8‑10.1)

Table 2: Mortality: frequencies, crude and standardized rates per year

Mortality		1999	2000	2001	2002	2003	2004	2005	2006	1999‑2006
Count		113	107	93	104	111	96	92	92	808
Crude rate		16.6	15.8	13.8	15.6	16.7	14.2	13.4	13.3	14.9 (13.9‑16.0)
Standardized rate	Italy 2001	13.1	12.1	10.3	11.7	12.5	10.3	10.1	9.9	11.2 (10.5‑12.1)
Standardized rate	Europe	9.2	8.7	7.0	8.4	9.1	7.0	7.2	6.8	7.9 (7.3‑8.6)
Standardized rate	World	6.4	6.0	4.7	5.9	6.2	4.7	4.9	4.6	5.4 (5.0‑5.9)

Table 3: Register quality indicators per year

Indicator	1999	2000	2001	2002	2003	2004	2005	2006	1999‑2006
Mortality/Incidence ratio (%)	75.3	62.1	55.4	68.0	78.6	61.7	68.7	63.5	66.3
Cito-histologically confirmed (%)	82.2	84.4	81.3	83.7	87.6	91.0	90.7	90.1	86.2
Death certificate only - DCO (%)	0.7	3.0	1.3	3.4	2.2	0.7	0.8	2.3	1.8

Table 4: Comparison of Italian Registries mean prevalence by macro-areas

Graf 04

_	Milan	North West	North East	Centre	South	Italy
Incidence	12.1	12.8	12.1	11.9	10.5	11.9
Mortality	7.5	8.5	7.2	6.5	5.2	7.0

Table 5: Basis of diagnosis per period

_	1999‑2002	%	2003‑2006	%	1999‑2006	%
Histological	487	79.2	468	86.5	955	82.6
Citological	23	3.7	18	3.3	41	3.6
Clinical	92	15.0	47	8.7	139	12.0
DCO	13	2.1	8	1.5	21	1.8

Table 6: More frequent morphologies

Morphology	N	%
Papillary serous cystadenocarcinoma (C56.9)	122	25.1
Serous cystadenocarcinoma, NOS (C56.9)	81	16.7
Endometrioid adenocarcinoma, NOS	65	13.4
Adenocarcinoma, NOS	58	11.9
Carcinoma, NOS	28	5.8
Mucinous cystadenocarcinoma, NOS (C56.9)	16	3.3

Table 7: Age distribution of rates

Graf 07

Age groups	Incidence	Mortality
0	0.0	0.0
1-4	0.0	0.0
5-9	0.0	0.0
10-14	0.0	0.0
15-19	1.2	0.0
20-24	0.0	0.0
25-29	1.3	0.0
30-34	0.9	0.0
35-39	7.2	0.5
40-44	10.5	0.5
45-49	16.9	7.0
50-54	18.6	7.8
55-59	29.7	20.2
60-64	35.0	24.1
65-69	35.4	30.7
70-74	44.4	33.0
75-79	38.5	43.8
80-84	51.1	45.0
85+	52.6	44.7

Table 8: Temporal trends of rates

Graf 08

Year	Mortality	Incidence
1999	9.2	13.2
2000	8.7	14.8
2001	7.0	14.9
2002	8.4	13.3
2003	9.1	12.1
2004	7.0	12.9
2005	7.2	11.0
2006	6.8	12.4

Table 10: Comparison of Italian Registries mean prevalence by macro-areas

Graf 10

Years since diagnosis	Italy	South	Centre	North East	North West	Milan
0-2	24.5	19.2	25.7	24.9	26.6	28.5
2-5	22.9	17.6	25.2	22.5	25.9	26.9
5-10	26.9	21.1	28.1	27.1	29.6	29.9
10-15	18.9	13.5	20.5	19.3	21.1	20.3
15-20	12.6	8.9	14.4	12.8	13.8	14.3
>20	26.7	17.6	28.2	26.7	31.6	30.9

Table 11: 5 years relative survival by macro-areas

Graf 11

Area	Relative survival (95% CI)
Milan	36.3 (32.8‑39.8)
North West	38.2 (36.3‑40.1)
North Est	37.3 (35.6‑39.0)
Centre	41.2 (38.3‑44.1)
South	35.4 (32.4‑38.4)
Italy	38.0 (36.9‑39.0)

Table 12: Relative survival by age since diagnosis

Age class	0	1	2	3	4	5
15-44	100.00	88.40	79.20	76.90	68.80	64.20
45-59	100.00	88.40	75.10	65.30	58.30	52.50
60-74	100.00	75.50	60.20	50.40	44.10	37.80
75+	100.00	43.30	30.40	26.70	23.60	19.80

Table 13: 5 years relative survival by biennium of incidence

Years since diagnosis	1999‑2000	2001‑2002	2003‑2004	2005‑2006
1	65.4	70.3	69.7	74.7
2	53.3	54.9	57.7	59.2
3	47.5	47.5	46.6	53.7
4	40.4	44	40.6	47.6
5	35.7	38.6	35.8	41.2

Table 14: Rates distribution by deprivation index

‑	1	2	3	4	5
Incidence	18.4	21.8	19.4	17.7	19.6
Mortality	11.1	13.9	14.2	14.2	16.3

Table 15: Relative survival by deprivation index

Years since diagnosis	Most deprived	Most affluent
0	100.0	100.0
1	70.7	78.7
2	54.4	61.1
3	48.3	49.4
4	44.0	43.5
5	37.5	37.4